ECSP961778A - COMPOSITIONS THAT INCREASE THE BIOAVAILABILITY OF PROTEINASE INHIBITORS - Google Patents

COMPOSITIONS THAT INCREASE THE BIOAVAILABILITY OF PROTEINASE INHIBITORS

Info

Publication number
ECSP961778A
ECSP961778A ECSP961778A ECSP961778A EC SP961778 A ECSP961778 A EC SP961778A EC SP961778 A ECSP961778 A EC SP961778A EC SP961778 A ECSP961778 A EC SP961778A
Authority
EC
Ecuador
Prior art keywords
bioavailability
compositions
increase
proteinase inhibitors
pharmaceutically acceptable
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Carole Anne Bailey
Josephine Christine Ferdinando
Navnit Shah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961778 priority Critical patent/ECSP961778A/en
Publication of ECSP961778A publication Critical patent/ECSP961778A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El invento se refiere a composiciones que incrementan la biodisponibilidad de inhibidores de proteinasa. La composición incluye un portador farmacéuticamente aceptable que comprnede monoglicéridos de ácidos grasos de cadena media.The invention relates to compositions that increase the bioavailability of proteinase inhibitors. The composition includes a pharmaceutically acceptable carrier that comprises medium chain fatty acid monoglycerides.

ECSP961778 1996-06-06 1996-06-06 COMPOSITIONS THAT INCREASE THE BIOAVAILABILITY OF PROTEINASE INHIBITORS ECSP961778A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961778 ECSP961778A (en) 1996-06-06 1996-06-06 COMPOSITIONS THAT INCREASE THE BIOAVAILABILITY OF PROTEINASE INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961778 ECSP961778A (en) 1996-06-06 1996-06-06 COMPOSITIONS THAT INCREASE THE BIOAVAILABILITY OF PROTEINASE INHIBITORS

Publications (1)

Publication Number Publication Date
ECSP961778A true ECSP961778A (en) 1997-11-04

Family

ID=42042508

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961778 ECSP961778A (en) 1996-06-06 1996-06-06 COMPOSITIONS THAT INCREASE THE BIOAVAILABILITY OF PROTEINASE INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP961778A (en)

Similar Documents

Publication Publication Date Title
EA199800023A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PROTEINASE INHIBITOR AND MONOGLYCERIDES
UY24248A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PROTEINASE INHIBITORS
DK0823895T3 (en) Fatty acid esters as bioactive compounds
EA200100249A1 (en) 4-AMINE SUBSTITUTE-2-SUBSTITUTE-1,2,3,4-TETRAHYDROCHINOLINE AS CETR INHIBITORS (CEPB)
BG103995A (en) Reverse hydroxamate inhibitors of matrix metalloprreverse hydroxamate inhibitors of matrix metallprooteinases teinases
EA200100519A1 (en) COMPOSITIONS ON THE BASIS OF A FINE-GROUNDED EPLERENON
AU5629701A (en) Pourable shortening composition
IT1307928B1 (en) METHOD OF SYNTHESIS OF NITROXYMETHYLPHENYL ESTERS OF ASPIRINE DERIVATIVES.
MY161871A (en) Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester
ES2139745T3 (en) GERMINATION INHIBITOR FOR POTATOES.
GR3031602T3 (en) Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
ES2044561T3 (en) ORIGINALLY ADMINISTRABLE LIQUID COMPOSITIONS BASED ON EDIBLE OILS.
IL126185A0 (en) Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
EP1148783A4 (en) CONVERSION OF COX INHIBITION COMPOSITIONS NOT CONSTITUTING SELECTIVE COX 2 INHIBITORS TO DERIVATIVES CONSTITUTING SELECTIVE COX 2 INHIBITORS
BG100248A (en) SQUALENSENTEZA INHIBITORS
TR200200494T2 (en) Fatty acid synthase inhibitors.
IL127154A0 (en) Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophoshoric acid
CA2183313A1 (en) Novel Indane-2-Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase
HK1047928A1 (en) Fatty acid synthase inhibitors
BG102638A (en) TABLETS WITH HIGH FLAVOR CONTENT
MX9204528A (en) 0ALL TO TREAT PREMENSTRUAL SYNDROME THROUGH ADMINISTRATION OF AN ANGIOTENSIN CONVERSION ENZYME INHIBITOR.
EP0832651A4 (en) Inhibitor for lipid peroxide increase
ES2151383A1 (en) Antiallergic agent having an anti-oxidant action
ES2187963T3 (en) PHARMACEUTICALLY ACCEPTABLE SALES OF 3-SULFATE 3-HYDROXY-ESTR-5 (10) -EN 17-ONA ACTIVE WITH STROGENS.
UY26337A1 (en) SOLID LIPID FORMULATIONS